Advanced search
Publication Cover
Cancer Management and Research Volume 14, 2022 - Issue
Submit an article Journal homepage
125
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

CSTF2 Acts as a Prognostic Marker Correlated with Immune Infiltration in Hepatocellular Carcinoma

Wang ZhangDepartments of Gastroenterology and Hepatology, First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-9416-8722
ORCID Icon,
Yipeng WanDepartments of Gastroenterology and Hepatology, First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China
,
Yue ZhangDepartments of Gastroenterology and Hepatology, First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China
,
Qi LiuDepartments of Gastroenterology and Hepatology, First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of China
&
Xuan ZhuDepartments of Gastroenterology and Hepatology, First Affiliated Hospital of Nanchang University, Nanchang, People’s Republic of ChinaCorrespondence[email protected]
Pages 2691-2709 | Published online: 27 Nov 2023

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yangjin Huang, Jun Xu, Chunming Xie, Yuejuan Liao, Rong Lin, Yuan Zeng & Fujun Yu. (2023) A Novel Gene Pair CSTF2/DPE2A Impacts Prognosis and Cell Cycle of Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1639-1657.
Read now
Jiaxiang Ding, Yue Su, Youru Liu, Yuanyuan Xu, Dashuai Yang, Xuefeng Wang, Shuli Hao, Huan Zhou & Hongtao Li. The role of CSTF2 in cancer: from technology to clinical application. Cell Cycle 0:0, pages 1-15.
Read now

Articles from other publishers (2)

Jianlin Chen, Gan Gao, Yi Zhang, Peng Dai & Yi Huang. (2023) Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma. BMC Cancer 23:1.
Crossref
Jianlin Chen, Wanzhen Zhuang, Yu Xia, Xiaoqing Yin, Mingshu Tu, Yi Zhang, Liangming Zhang, Hengbin Huang, Songgao Zhang, Lisheng You & Yi Huang. (2023) Construction and validation of a novel IGFBP3-related signature to predict prognosis and therapeutic decision making for Hepatocellular Carcinoma. PeerJ 11, pages e15554.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.